H-Ala-Pro-AFC
| Name | H-Ala-Pro-AFC |
| Category | Enzyme Substrates and Inhibitors |
| One Letter Code | AP-AFC |
| Three Letter Code | {Ala}{Pro}-AFC |
| Molecular Weight | 397.350 |
| Application | Hematology |
| Steven, Sebastian, et al. "Glucagon‐like peptide‐1 receptor signalling reduces microvascular thrombosis, nitro‐oxidative stress and platelet activation in endotoxaemic mice." British journal of pharmacology 174.12 (2017): 1620-1632. |
| Schnapp, Gisela, et al. "Comparative analysis of binding kinetics and thermodynamics of dipeptidyl peptidase-4 inhibitors and their relationship to structure." Journal of medicinal chemistry 59.16 (2016): 7466-7477. |
| Chen, Meihua, et al. "A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts." Scientific reports 5.1 (2015): 1-14. |
| Keane, Fiona M., et al. "Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs." FEBS open bio 4 (2014): 43-54. |
| Shah, Payal, et al. "The DPP-4 inhibitor linagliptin restores β-cell function and survival in human isolated islets through GLP-1 stabilization." The Journal of Clinical Endocrinology & Metabolism 98.7 (2013): E1163-E1172. |
| Kern, Matthias, et al. "Linagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesity." PloS one 7.6 (2012). |